A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects

NCT00894660 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Falciparum Malaria

Interventions

DRUG: Amodiaquine (Test)
DRUG: Amodiaquine (Comparator)

Sponsor

Pfizer